Anti-Nucleocapsid (NP) Antibody Variant 2
InVivo offers a series of different monoclonal antibodies for the detection of the Nucleocapsid protein (NP) from SARS-CoV-2. All antibodies come from hybridoma cell lines that were generated by immunization with recombinant N-protein. In SARS-CoV-2 antigen tests, the N-protein is usually targeted, as it is less prone to mutations compared to the Spike (S) protein, and thus is less likely to evade antibody detection.
Out of stock
Delivery time: Depending on production time
From: 400,00 € Excl. VAT and delivery costs
Please contact us for larger quantities.
InVivo offers a series of different monoclonal antibodies for the detection of the Nucleocapsid protein (NP) from SARS-CoV-2. All antibodies come from hybridoma cell lines that were generated by immunization with recombinant N-protein. In SARS-CoV-2 antigen tests, the N-protein is usually targeted, as it is less prone to mutations compared to the Spike (S) protein, and thus is less likely to evade antibody detection.
All anti-Nucleocapsid protein (NP) antibodies have been independently tested and are recommended and for use in sandwich ELISA assays.
The antibody is produced exclusively under serum-free conditions from hybridoma and purified through one-step purification with Protein-G affinity chromatography.
| Product-ID: | AK3433.1 |
|---|---|
| Host: | Mouse |
| Clonality: | Monoclonal |
| Isotype: | mIgG |
| Subclass: | mIgG2b |
| Formulation: | Liquid, PBS, pH 7.4, 0.2 μm sterile filtered |
| Concentration: | > 0.5 mg/ mL |
| Purity: | > 90% (via analytical CGE under reducing conditions) |
| Conjugate: | Unconjugated |
The product is for research use or for further manufacturing only.
Additional information
| Document | |
|---|---|
| Notice | The product is for research use or for further manufacturing only. |
You must be logged in to post a review.
Reviews
There are no reviews yet.